|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.00 INR | +0.53% |
|
+0.53% | -9.74% |
Company Valuation: Clinitech Laboratory Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 |
|---|---|
| Market Cap 1 | 91.84 |
| Change | - |
| Enterprise Value (EV) 1 | 61.1 |
| Change | - |
| P/E Ratio | 21.2x |
| PBR | 1.04x |
| PEG | -1.1x |
| Capitalization / Revenue | 1.12x |
| EV / Revenue | 0.74x |
| EV / EBITDA | 7.09x |
| EV / EBIT | 14.8x |
| EV / FCF | - |
| FCF Yield | - |
| Dividend per Share 2 | - |
| Rate of return | - |
| EPS 2 | 1.896 |
| Distribution rate | - |
| Net sales 1 | 82.35 |
| EBITDA 1 | 8.62 |
| EBIT 1 | 4.122 |
| Net income 1 | 3.947 |
| Net Debt 1 | -30.75 |
| Reference price 2 | 40.24 |
| Nbr of stocks (in thousands) | 2,282 |
| Announcement Date | 26/08/25 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 906K | |
| -132.4x | 10.86x | -150.21x | -.--% | 31.4B | |
| 18.43x | 1.79x | 10.33x | 1.1% | 21.75B | |
| 16.58x | 1.29x | 7.31x | 5.31% | 7.01B | |
| 298.46x | - | - | - | 4.58B | |
| 52.52x | 9.27x | 32.53x | 0.88% | 2.78B | |
| -20.35x | - | - | - | 1.81B | |
| 32.26x | 1.39x | 11.33x | 1.67% | 1.61B | |
| 11.92x | 1.26x | 4.94x | 6.34% | 1.6B | |
| 26.3x | 1.06x | 8.78x | 0.96% | 1.51B | |
| Average | 33.75x | 3.85x | -10.72x | 2.32% | 7.41B | |
| Weighted average by Cap. | -27.74x | 6.21x | -63.70x | 1.15% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 544220 Stock
- Valuation Clinitech Laboratory Limited
Select your edition
All financial news and data tailored to specific country editions
